---
title: "BriaCell Reports \"Late-Breaker\" Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/238288125.md"
description: "PHILADELPHIA and VANCOUVER, British Columbia, April 30, 2025 ( GLOBE NEWSWIRE ) -- BriaCell Therapeutics Corp. ( Nasdaq: BCTX, BCTXW, BCTXZ ) ( TSX: BCT ) ( \"BriaCell\" or the \"Company\" ) , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is ..."
datetime: "2025-04-30T12:33:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238288125.md)
  - [en](https://longbridge.com/en/news/238288125.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238288125.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/238288125.md) | [English](https://longbridge.com/en/news/238288125.md)


# BriaCell Reports "Late-Breaker" Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified

PHILADELPHIA and VANCOUVER, British Columbia, April 30, 2025 ( GLOBE NEWSWIRE ) -- BriaCell Therapeutics Corp. ( Nasdaq: BCTX, BCTXW, BCTXZ ) ( TSX: BCT ) ( "BriaCell" or the "Company" ) , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is ...

### 相關股票

- [BriaCell Therapeutics (BCTX.US)](https://longbridge.com/zh-HK/quote/BCTX.US.md)

## 相關資訊與研究

- [BriaCell subsidiary BriaPro posts $472k net loss, $1.61M related-party debt and closes sCD80 license deal](https://longbridge.com/zh-HK/news/281237757.md)
- [BriaCell Therapeutics Signs Multiple Material Agreements](https://longbridge.com/zh-HK/news/272747763.md)
- [Leoch Shelves Planned U.S. Spin-Off amid Market and Regulatory Headwinds](https://longbridge.com/zh-HK/news/281423685.md)
- [BriaCell Reports 11-Month Complete Lung Metastasis Resolution in Metastatic Breast Cancer Trial](https://longbridge.com/zh-HK/news/272411373.md)
- [BriaCell Therapeutics Reports Positive Phase 3 Data for Bria-IMT Regimen in Metastatic Breast Cancer](https://longbridge.com/zh-HK/news/271812047.md)